A phase 1 open label study to assess the human mass balance and metabolite profile of 14C-fosmanogepix, a novel Gwt-1 inhibitor in healthy male participants microbiologystudyBy sharad / July 16, 2024 Antimicrobial Agents and Chemotherapy, Ahead of Print. Source link